Bristol-Myers Squibb (BMY) Insider Trading & Ownership $60.10 +1.20 (+2.04%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$59.96 -0.13 (-0.22%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Bristol-Myers Squibb (NYSE:BMY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.09%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$200,019.42Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$38,934.00 Get BMY Insider Trade Alerts Want to know when executives and insiders are buying or selling Bristol-Myers Squibb stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BMY Insider Buying and Selling by Quarter Remove Ads Bristol-Myers Squibb Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/14/2025Samit HirawatEVPBuy1,823$54.84$99,973.32 1/15/2025Julie JohnsonU.S. Congress Member (D-TX)Buy$55.96$1,001 - $15,00012/6/2024Virginia FoxxU.S. Congress Member (R-NC)Buy$59.38$1,001 - $15,00011/4/2024Phil M HolzerSVPSell700$55.62$38,934.00 11/1/2024Samit HirawatEVPBuy1,830$54.67$100,046.10 (Data available from 1/1/2013 forward) BMY Insider Trading Activity - Frequently Asked Questions Who is on Bristol-Myers Squibb's Insider Roster? The list of insiders at Bristol-Myers Squibb includes Ann Powell, Christopher S Boerner, David V Elkins, Giovanni Caforio, Phil M Holzer, Robert M Plenge, Rupert Vessey, Samit Hirawat, Sandra Leung, and Theodore R Samuels II. Learn more on insiders at BMY. What percentage of Bristol-Myers Squibb stock is owned by insiders? 0.09% of Bristol-Myers Squibb stock is owned by insiders. Learn more on BMY's insider holdings. Which Bristol-Myers Squibb insiders have been buying company stock? The following insiders have purchased BMY shares in the last 24 months: Christopher S Boerner ($249,609.06), Samit Hirawat ($200,019.42), and Theodore R Samuels II ($423,385.00). How much insider buying is happening at Bristol-Myers Squibb? Insiders have purchased a total of 17,224 BMY shares in the last 24 months for a total of $873,013.48 bought. Which Bristol-Myers Squibb insiders have been selling company stock? The following insiders have sold BMY shares in the last 24 months: Ann Powell ($1,101,642.50), Phil M Holzer ($38,934.00), Robert M Plenge ($44,754.48), and Rupert Vessey ($3,378,818.10). How much insider selling is happening at Bristol-Myers Squibb? Insiders have sold a total of 69,803 Bristol-Myers Squibb shares in the last 24 months for a total of $4,564,149.08 sold. Which members of congress are trading Bristol-Myers Squibb? Julie Johnson (D-TX), Virginia Foxx (R-NC), and Tommy Tuberville (R-AL) have bought shares of Bristol-Myers Squibb in the last year totaling $24,000. Tommy Tuberville (R-AL) has sold shares totaling $8,000. Bristol-Myers Squibb Key ExecutivesDr. Christopher S. Boerner Ph.D. (Age 53)CEO & Chairman Compensation: $3.14MMr. David V. Elkins (Age 56)Executive VP & CFO Compensation: $2.28MMs. Sandra Leung Esq. (Age 63)Executive VP & General Counsel Compensation: $2.58MMr. Samit Hirawat M.D. (Age 55)Executive VP, Chief Medical Officer & Head of Development Compensation: $2.62M2 recent tradesMr. Greg Meyers (Age 51)Executive VP and Chief Digital & Technology Officer Mr. Timothy PowerVP & Head of Investor RelationsMs. Kimberly M. JablonskiChief Compliance & Ethics OfficerMs. Ahn Amanda Poole (Age 49)Executive Vice President & Chief Human Resources Officer Dr. Joseph J. Eiden Jr. (Age 75)Head of Medical Affairs Mr. Adam Lenkowsky (Age 52)Executive VP, Chief Commercialization Officer & Head of U.S. Oncology More Insider Trading Tools from MarketBeat Related Companies Johnson & Johnson Insider Buying AbbVie Insider Buying Merck & Co., Inc. Insider Buying Pfizer Insider Buying Zoetis Insider Buying Royalty Pharma Insider Buying Jazz Pharmaceuticals Insider Buying Corcept Therapeutics Insider Buying Perrigo Insider Buying Supernus Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NYSE:BMY) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
